Opportunities and Challenges in Cardio-Oncology: A Bibliometric Analysis From 2010 to 2022
- PMID: 35500730
- DOI: 10.1016/j.cpcardiol.2022.101227
Opportunities and Challenges in Cardio-Oncology: A Bibliometric Analysis From 2010 to 2022
Abstract
Cardio-oncology has grown rapidly worldwide as an emerging interdisciplinary discipline over the past decade. In the present bibliometric review, we employed VOSviewer and Citespace software to describe the literature landscape concerning cardio-oncology from 2010 to 2022. As a result, a total of 1,194 relevant publications were identified in the Web of Science database with an increasing trend. The United States dominated the field during the research period, and Italy, England and Canada had emerged as significant contributors to the study. Ky. Bonnie, Herrmann. Joerg and Fradley. Michael G were the most productive researchers. JACC: CardioOncology was the journal dedicated to the discipline of cardio-oncology and had published the greatest number of papers. Vascular disease and atrial fibrillation have attracted much attention as the main cardiovascular burden. Immune checkpoint inhibitor-specific cardiovascular toxicity, biomarkers and imaging examination together with the prevention of cardio-oncology are potential research hotspots. Notably, basic research is lagging behind, for which more researches are needed to fill the gap. In conclusion, bibliometric analysis provided valuable information for the development of cardio-oncology, which is full of opportunities and challenges.
Copyright © 2022 The Author(s). Published by Elsevier Inc. All rights reserved.
Comment in
-
Comment on "Opportunities and Challenges in Cardio-Oncology: A Bibliometric Analysis From 2010 to 2022".Curr Probl Cardiol. 2023 Sep;48(9):101778. doi: 10.1016/j.cpcardiol.2023.101778. Epub 2023 May 11. Curr Probl Cardiol. 2023. PMID: 37172879 No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous
